Autopsy report · NCT02550054

Erythropoietin in Premature Infants to Prevent Encephalopathy

“The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 58 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Children's Hospital of Fudan University

Sponsor type

University, hospital or other

Conditions

Premature Infant

Interventions

Epo; Normal saline

Participants

58

Sites

1

Countries

China

Trials that died the same way

• AI-assisted cEEG Diagnosis of Neonatal Seizures in Neonatal Intensive Care Unit
  “The other study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.” (97% match in meaning)
• Feeding After Neonate Surgery Review
  “sufficient data gathered for study conclusion” (61% match in meaning)
• PFC Sigma Fixed and Mobile Knee Study
  “The study was terminated at the point the primary endpoint and early milestones were reached and because long term outcomes were available from other sources” (60% match in meaning)
• A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
  “Upon interim analysis, sufficient data was accrued to assess study hypotheses.” (60% match in meaning)
• Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma
  “Early termination (regarding the follow-up of the patients). The required sample size was reached, and the primary endpoint was met.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.